Anti-Doping activities of International Soft Tennis Federation(ISTF)
ISTF Anti-Doping Rules was approved by the General Assembly of ISTF which took place in Anseong, Korea in 2007. As explained by the General Assembly of ISTF in Mungyeong Korea in 2011, the following activities have been made.
01 ISTF Doping Hearing Panel was established.
This Panel is to judge "violated or not violated" when there is doubt of doping through doping testing and to judge what consequence has to be posed when it is judged as "violated".
The Doping Hearing Panel was established with the following members in 2011.
Chairman: Professor (Ms.) Rieko Yamashita (Japan)
Member: Dr.(Ms.) Dangsina Moeloek (Indonesia)
Mr. Chuluun Nasanbat ( Mongolia )
Mr. Myungsu Kim ( Korea )
Mr. Yu Zhu ( China )
02 TUE(Therapeutic Use Exemption) Committee was established.
An athlete may have an illness or condition that requires a particular medication. If this medication appears on the Prohibited List, the athlete may be granted a Therapeutic Use Exemption (TUE) which gives the athlete permission to take it through request by filling TUE form. This Committee is to examine and control the request.
TUE Committee was established with the following members in 2011.
Chairman: Dr.(Mr.)Kang Kiwon (Korea)
Member: Dr.(Mr.)Hironori Nagai (Japan)
Dr.(Ms).Yoshiko Fujishima ( Japan )
03 RTP (Registered Testing Pool) list is provided.
All athletes listed in RTP need to provide whereabouts details so that anti-doping
authorities can ensure all athletes play true through in-competition testing and out-of-competition testing which may be made in a training place, a working place etc at any time without pre-notice. If an athlete rejects to have the testing, he/she is considers as violator.
Registered Testing Pool Athlete (RTPA) has obligation to submit whereabouts information every 3 months. In accordance with this information out-of-competition testing is made.
RTPA is provided by Korea and Japan at the first stage. The whereabouts information is maintained under the supervision of ISTF. Whereabouts information from other countries than Korea and Japan is expected to be received as well from now on.
04 In-Competition testing
Testing is to be made to athletes at an International Competition.
05 Out-of-Competition testing
Testing is to be made to RTPA according to his/her whereabouts information.
06 Education for anti-doping activities
In parallel with anti-doping activities by member countries, ISTF is promoting education for anti-doping to athletes of member countries. In 2011 the joint education activity ISTF Soft Tennis Camp was held in Hiroshima , Japan in July in 2011, where outline of the anti-doping and the testing procedures were lectured to mainly athletes from Korea , Mongol and Japan .
Continuous education activities such as
- training camp organized by ISTF
- distribution of the latest information of anti-doping to member countries
- maintenance of whereabouts information of RTPA
are made from now on as well.
07 PR of the anti-doping activities
ISTF made balls printed with the logo of "Say No to Doping!" which is proposed by WADA and ISTF makes PR activities, for example, by using the balls on each event.
08 Stage (Seal the Sample)
Seal the A and B bottles.
09 Stage (Specific Gravity)
The DCO will measure the specific gravity of the sample to ensure it is not too diluted to analyze. If it is too dilute, an athlete may be required to provide additional samples.
10 Stage (Sign the Form)
An athlete will complete the Doping Control Form, by
- providing personal information
- noting any substances the athlete may be taking: prescription medication, over the counter medication and supplements
- noting concerns or comments, if the athlete have nay, about the doping control
- confirming the information, recorded numbers and samples code are correct
- signing and receiving the athlete's copy of the doping control form
11 Stage (Sample Analysis)
Samples will be sent to a WADA accredited laboratory in strict confidentiality and will be tracked to ensure their security. An athlete's A sample will be analyzed and the athlete's B sample will be securely stored for further testing if required. The laboratory will send the results to the responsible anti-doping organization (ADO) and WADA.
Athlete Rights and Responsibilities
An athlete has the right to:
- have a representative and, if available, an interpreter
- ask for additional information about the sample collection process
- request a delay in reporting to the Doping Control Station for valid reasons (as determined by the DCO)
- if an athlete is with a disability, to request modifications to the samples collection procedure
An athlete has a responsibility to:
- remain within direct observation of the DCO/chaperone at all times from the point of notification until the completion of the sample collection process
- procedure appropriate identification
- comply with sample collection procedures (failure to do so may constitute an anti-doping rule violation)
- report immediately for doping control, unless there are compelling reasons for a delay